Abstract
Gourlet, P., P. De Neef, J. Cnudde, M. Waelbroeck and P. Robberecht. In vitro properties of a high affinity selective antagonist of the VIP 1 receptor. Peptides 18(10) 1555–1560, 1997.—A selective high affinity VIP 1 receptor antagonist [Acetyl-His 1, D-Phe 2, Lys 15, Arg 16, Leu 17] VIP(3-7)/GRF(8-27) or PG 97-269 was synthesized, by analogy with recently obtained selective VIP 1 receptor agonists. The properties of the new peptide were evaluated on Chinese hamster ovary (CHO) cell membranes expressing either the rat VIP 1-, rat VIP 2- or the human VIP 2- recombinant receptors and on LoVo cell membranes expressing exclusively the human VIP 1 receptor. The IC 50 values of 125I-VIP binding inhibition by PG 97-269 were 10, 2000, 2 and 3000 nM on the rat VIP 1-, rat VIP 2-, human VIP 1- and human VIP 2 receptors, respectively. PG 97-269 had a negligible affinity for the PACAP I receptor type. It did not stimulate adenylate cyclase activity, but inhibited competitively effect of VIP on the VIP 1 receptor mediated stimulation of adenylate cyclase activity. The K i values were respectively of 15 ± 5 nM and 2 ± 1 nM for the rat and human VIP 1 receptors. Thus the described molecule in the first reported VIP antagonist with an affinity in the nM range and with a high selectivity for the VIP 1 receptor subclass. It may be useful for evaluation of the physiological role of VIP in rat and human tissues.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
